tiprankstipranks
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID
US Market
OVID
Ovid Therapeutics
RESEARCH TOOLSreports

Ovid Therapeutics (OVID) Stock News & Sentiment

1,745 Followers
Ovid Therapeutics: Undervalued KCC2 Platform and Upcoming OV4071 Catalyst Support Buy Rating
Premium
Ratings
Ovid Therapeutics: Undervalued KCC2 Platform and Upcoming OV4071 Catalyst Support Buy Rating
3d ago
OVID
3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
5d ago
IVA
OVID
Regulatory Timing Risks Mount for Ovid Therapeutics as FDA Funding and Staffing Volatility Threaten Drug Approval Timelines
Premium
Company Announcements
Regulatory Timing Risks Mount for Ovid Therapeutics as FDA Funding and Staffing Volatility Threaten Drug Approval Timelines
24d ago
OVID
Ovid Therapeutics: Advancing OV329 Pipeline, De‑Risked Differentiation, and Strong Cash Runway Support Buy Rating
Premium
Ratings
Ovid Therapeutics: Advancing OV329 Pipeline, De‑Risked Differentiation, and Strong Cash Runway Support Buy Rating
25d ago
OVID
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
Premium
TipRanks Newswire
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
25d ago
CING
OVID
Ovid Therapeutics Raises Capital to Expand Epilepsy Pipeline
Premium
Company Announcements
Ovid Therapeutics Raises Capital to Expand Epilepsy Pipeline
25d ago
8K
OVID
OVID Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
OVID Earnings this Week: How Will it Perform?
29d ago
OVID
More OVID News >

OVID News on the Web

Ovid Therapeutics: Undervalued KCC2 Platform and Upcoming OV4071 Catalyst Support Buy Rating
TipRanks News
Bullish
Ovid Therapeutics price target raised to $4 from $2 at H.C. Wainwright
TipRanks News
Bullish
Wedbush Reaffirms Ovid Therapeutics At Outperform With Price Target Of $7
rttnews
Bullish
Top Analysts Are Loading Up on These 3 Stocks Right Now
TipRanks News
Bullish
Ovid Therapeutics (OVID) Gets a Buy from Wedbush
TipRanks News
Bullish
LifeSci Capital Sticks to Their Buy Rating for Ovid Therapeutics (OVID)
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ovid Therapeutics (OVID) and Hologic (HOLX)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Knight Therapeutics (OtherKHTRF) and Ovid Therapeutics (OVID)
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
OVID
Sector Average
Media Buzz
This Week5 articles
Weekly Average6 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OVID’s Media Buzz Sentiment?
5 articles about OVID were published this week. In an average week, 6 articles are published.
    What is OVID’s weekly average amount of articles?
    In an average week, 6 articles about OVID are published.
      What is OVID’s News Sentiment?
      100% of articles about OVID were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week